The applied MALDI-TOF MS and MS/MS strategy presented here allowed for the characterization of glycans bearing the ABO(H) blood group antigens which, like genetic factors, are involved in several hemostasis-related diseases [26,27] and in many infectious diseases [28,29,30,31,32,33]. This evidence concerns the gene ABO and infectious disease.